Biological activity of megalomicin, a new Micromonospora-produced macrolide antibiotic complex.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity / Q000652:urine; D004285:Dogs; D004917:Erythromycin / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D007709:Klebsiella / Q000187:drug effects; D051379:Mice; D008847:Micromonospora / Q000378:metabolism*; D008970:Molecular Weight; D011549:Pseudomonas / Q000187:drug effects; D051381:Rats; D013210:Staphylococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects
D000900:Anti-Bacterial Agents; D004917:Erythromycin